HMM302 - Innovations in Medical Biotechnology
Unit details
| Year | 2025 unit information |
|---|---|
| Enrolment modes: | Trimester 1: Burwood (Melbourne), Waurn Ponds (Geelong) |
| Credit point(s): | 1 |
| EFTSL value: | 0.125 |
| Unit Chair: | Trimester 1: Jessy Vibin |
| Prerequisite: | HMM101 or HMM201 |
| Corequisite: | Nil |
| Incompatible with: | Nil |
| Educator-facilitated (scheduled) learning activities - on-campus unit enrolment: | 1 x 2 hour online live lecture per week |
| Typical study commitment: | Students will on average spend 150 hours over the teaching period undertaking the teaching, learning and assessment activities for this unit. This will include educator guided online learning activities within the unit site. |
Content
This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.
Learning Outcomes
| ULO | These are the Unit Learning Outcomes (ULOs) for this unit. At the completion of this unit, successful students can: | Alignment to Deakin Graduate Learning Outcomes (GLOs) |
|---|---|---|
| ULO1 | Analyse the key principles of innovation and operational management of medical biotechnology. | GLO1: Discipline-specific knowledge and capabilities |
| ULO2 | Evaluate the general business strategies and marketing concepts of medical biotechnology and how funding for medical biotechnology is secured. | GLO2: Communication |
| ULO3 | Detail key regulatory and legal issues in medical biotechnology, including intellectual property, biopatenting, licencing and registration of therapeutics. | GLO3: Digital literacy |
| ULO4 | Discuss the social and ethical aspects of medical and pharmaceutical biotechnology. | GLO4: Critical thinking |
| ULO5 | Apply the principles of risk management in a medical biotechnology context. | GLO5: Problem solving |
| ULO6 | Critically analyse and evaluate developments in medical and pharmaceutical biotechnology in industries, research institutions and big pharma. | GLO6: Self-management |
Assessment
Trimester 1:| Assessment description | Student output | Grading and weighting (% total mark for unit) | Indicative due week |
|---|---|---|---|
| Assessment 1: Trimester test 1 | 45 minutes | 25% |
|
| Assessment 2: Trimester test 2 | 45 minutes | 25% |
|
| Assessment 3: Weekly workshop assessment | Short answer or multiple-choice questions | 20% |
|
| Assessment 4: Poster with recorded video presentation | 1200 - 1500 words | 30% |
|
The assessment due weeks provided may change. The Unit Chair will clarify the exact assessment requirements, including the due date, at the start of the teaching period.
Learning resource
There is no prescribed text. Unit materials are provided via the unit site. This includes unit topic readings and references to further information.
Unit Fee Information
Fees and charges vary depending on the type of fee place you hold, your course, your commencement year, the units you choose to study and their study discipline, and your study load.
Tuition fees increase at the beginning of each calendar year and all fees quoted are in Australian dollars ($AUD). Tuition fees do not include textbooks, computer equipment or software, other equipment or costs such as mandatory checks, travel and stationery.
For further information regarding tuition fees, other fees and charges, invoice due dates, withdrawal dates, payment methods visit our Current Students website.